Key result
PHACTR1 variant is linked to ~2.7-fold higher CAD risk in smokers.
Why the study?
Do specific genetic polymorphisms increase the risk of coronary artery disease in smokers without other traditional cardiovascular risk factors?
Case-Control (n=134)
Do specific genetic polymorphisms increase the risk of coronary artery disease in smokers without other traditional cardiovascular risk factors?
Answers are grounded in this paper and cite their sources.
The PHACTR1 genetic variant is associated with a 2.7-fold increased risk of coronary artery disease in smokers who lack other traditional cardiovascular risk factors.
Introduction Coronary arterial disease (CAD) poses a significant public health challenge, with tobacco recognized as the most predominant modifiable risk factor in young individuals. Despite a strong correlation between tobacco use and cardiovascular (CV) events, many smokers remain event-free. This fact raises questions about the complex interplay of environmental, epigenetic, and genetic factors contributing to CAD. Objective To identify genetic polymorphisms potentially responsible for CAD in smokers without other cardiovascular risk factors. Methods A case-control study involved individuals with low-density lipoprotein (LDL) levels <100mg/dl who were non-diabetic and non-hypertensive. 134 individuals (83% men; age 48.9±8.4 years) were enrolled, comprising 97 CAD patients (defined as having at least 70% stenosis in one major coronary artery) and 37 controls without CAD. Eight polymorphisms previously associated with CAD but not with traditional risk factors (TRFs) were genotyped using TaqMan real-time PCR: CDKN2B-AS1 (rs1333049/rs4977574), TCF21 (rs12190287), PHACTR1 (rs1332844), MIA3 (rs17465637), ADAMTS7 (rs3825807), ZC3HC1 (rs11556924), SMAD3 (rs17228212), and GJA4 (rs618675). Bivariate and multivariate analyses compared genotypic proportions between CAD and non-CAD groups. Results The PHACTR1 polymorphism (rs1332844 TT/TC) was significantly more prevalent in the CAD cohort, with 86.6% of CAD patients exhibiting this genotype compared to 70.3% of controls (p=0.028). After multivariate analysis of the eight polymorphisms, the PHACTR1 variant remained associated with CAD (OR 2.7; p=0.031). No other genetic variant examined was associated with CAD in this population. Conclusion The PHACTR1 variant is linked to an increased risk of CAD in smokers without other main CV risk factors. This gene encodes a phosphatase and actin regulator protein involved in endothelial cell stabilization, suggesting a synergistic effect of smoking and the PHACTR1 endothelial dysfunction.
No takes yet. Share an insight, caveat, or question.
Sousa et al. (2025) conducted a case-control in Coronary artery disease in smokers (n=134). PHACTR1 polymorphism (rs1332844 TT/TC) vs. Absence of the polymorphism / Controls without CAD was evaluated on Presence of coronary artery disease (at least 70% stenosis in one major coronary artery) (OR 2.7, p=0.031). The PHACTR1 polymorphism (rs1332844 TT/TC) was more prevalent in smokers with CAD than controls and remained independently associated with CAD.
Synapse has enriched 10 related papers. Consider them for comparative context: